BRANDY SCOTT: Open Payments
NPI 1649338849 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 73 payments from 12 companies in 2025. Trend: 2023 $820 · 2024 $740 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $301 |
| ABBVIE INC. | 14 | $198 |
| Amgen Inc. | 14 | $182 |
| Amneal Pharmaceuticals LLC | 10 | $135 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, OTEZLA, UNITHROID, FANAPT, INSPIRE, The Cologuard Plus Collection Kit, Ozempic.
Industry payments across GA — which companies pay providers there.
